Hydrogenology
Source-linked study record

Therapeutic potential of hydrogen-rich water in zebrafish model of Alzheimer’s disease: targeting oxidative stress, inflammation, and the gut-brain axis

He J, Xu P, Xu T, Yu H, Wang L, Chen R, Zhang K, Yao Y, Xie Y, Yang Q, Wu W, Sun D, Wu D. · Frontiers in aging neuroscience. 2024;16:1515092.

PreclinicalH₂-rich waterPublished 2024Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

Adult zebrafish in an aluminum-chloride Alzheimer-like model, with separate zebrafish-larva assays.

Intervention and dose

Adult HRW group: aquarium water at 1,000 ppb dissolved H₂ for 10 hours/day, followed by 14 hours/day in the normal environment, for 7 days. Separate larval experiment: 1,000 ppb HRW for 3 days after 4 days of Al³⁺ exposure; medium was renewed daily. · Dissolved H₂ target: 1,000 ppb (approximately 1 mg/L). The reported 20-minute period was the water-preparation time needed to reach the target concentration, not the zebrafish exposure duration.

Duration

Adults: 10 hours/day for 7 days. Larvae: 3 days in a separate experiment.

Reported result

The article reports less amyloid-β deposition, lower inflammatory and oxidative-stress measures, altered sEH/EET measures and partial behavioral and microbiota improvements in HRW-treated zebrafish versus the Alzheimer-model group. This is preclinical evidence only.

Main limitation

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Controlled preclinical study

Research topic

Other neurological conditions

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

Adult zebrafish in an aluminum-chloride Alzheimer-like model, with separate zebrafish-larva assays.

Sample

Adult experiment: three groups of 120 zebrafish each. Separate larval and assay-level analyses used smaller source-reported subsamples.

Duration

Adults: 10 hours/day for 7 days. Larvae: 3 days in a separate experiment.

Intervention

Adult HRW group: aquarium water at 1,000 ppb dissolved H₂ for 10 hours/day, followed by 14 hours/day in the normal environment, for 7 days. Separate larval experiment: 1,000 ppb HRW for 3 days after 4 days of Al³⁺ exposure; medium was renewed daily.

Hydrogen form

H₂ dissolved in drinking water — H₂ only unless the full text explicitly reports oxygen co-delivery.

Dose or H₂ specification

Dissolved H₂ target: 1,000 ppb (approximately 1 mg/L). The reported 20-minute period was the water-preparation time needed to reach the target concentration, not the zebrafish exposure duration.

Comparator

Adult control and Alzheimer-model groups remained in normal water; the larval experiment used corresponding control and aluminum-exposed conditions.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Behavior and cognition, amyloid-β deposition, neuroinflammation, oxidative-stress markers, liver sEH/EET measures and gut microbiota.

Reported result

The article reports less amyloid-β deposition, lower inflammatory and oxidative-stress measures, altered sEH/EET measures and partial behavioral and microbiota improvements in HRW-treated zebrafish versus the Alzheimer-model group. This is preclinical evidence only.

Extraction completeness

The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.

Applies directly to

Applies to the reported animal, cell or tissue model, not directly to patients.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 39839307 · DOI: 10.3389/fnagi.2024.1515092

Publisher access

A free full article is available through PubMed Central.

Extraction basis

Official PubMed/PMC full article; record re-audited and corrected 25 August 2026.

Last reviewed

25 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.